Literature DB >> 14638578

The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.

Mauricio Tohen1, Carlos A Zarate, John Hennen, Hari-Mandir Kaur Khalsa, Stephen M Strakowski, Priscilla Gebre-Medhin, Paola Salvatore, Ross J Baldessarini.   

Abstract

OBJECTIVE: Since improved prediction of illness course early in bipolar disorder is required to guide treatment planning, the authors evaluated recovery, first recurrence, and new illness onset following first hospitalization for mania.
METHOD: Bipolar disorder patients (N=166) were followed 2-4 years after their first hospitalization for a manic or mixed episode to assess timing and predictors of outcomes. Three aspects of recovery were measured: syndromal (DSM-IV criteria for disorder no longer met), symptomatic (Young Mania Rating Scale score </=5 and Hamilton Depression Rating Scale score </=8), and functional (regaining of premorbid occupational and residential status). Rates of remission (syndromal recovery sustained >/=8 weeks), switching (onset of new dissimilar illness before recovery), relapse (new episode of mania within 8 weeks of syndromal recovery), and recurrence (new episode postremission) were also assessed.
RESULTS: By 2 years, most subjects achieved syndromal recovery (98%, with 50% achieving recovery by 5.4 weeks); 72% achieved symptomatic recovery. Factors associated with a shorter time to syndromal recovery for 50% of the subjects were female sex, shorter index hospitalization, and lower initial depression ratings. Only 43% achieved functional recovery; these subjects were more often older and had shorter index hospitalizations. Within 2 years of syndromal recovery, 40% experienced a new episode of mania (20%) or depression (20%), and 19% switched phases without recovery. Predictors of mania recurrence were initial mood-congruent psychosis, lower premorbid occupational status, and initial manic presentation. Predictors of depression onset were higher occupational status, initial mixed presentation, and any comorbidity. Antidepressant treatment was marginally related to longer time to recovery and earlier relapse.
CONCLUSIONS: Within 2-4 years of first lifetime hospitalization for mania, all but 2% of patients experienced syndromal recovery, but 28% remained symptomatic, only 43% achieved functional recovery, and 57% switched or had new illness episodes. Risks of new manic and depressive episodes were similar but were predicted by contrasting factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638578     DOI: 10.1176/appi.ajp.160.12.2099

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  92 in total

1.  McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.

Authors:  Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini
Journal:  J Clin Psychiatry       Date:  2010-07-13       Impact factor: 4.384

2.  Easing the burden of bipolar disorder: from urgent situations to remission.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

3.  Cognition and the differential diagnosis of schizophrenia.

Authors:  Philip D Harvey
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

4.  Negative Affective Features in 516 Cases of First Psychotic Disorder Episodes: Relationship to Suicidal Risk.

Authors:  Paola Salvatore; Ross J Baldessarini; Hari-Mandir K Khalsa; Premananda Indic; Carlo Maggini; Mauricio Tohen
Journal:  J Depress Anxiety       Date:  2013-07-27

5.  Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.

Authors:  Christoph U Correll; Julie B Penzner; Anne M Frederickson; Jessica J Richter; Andrea M Auther; Christopher W Smith; John M Kane; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2007-05-02       Impact factor: 9.306

6.  Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study.

Authors:  Kaan Kora; Mete Saylan; Cengiz Akkaya; Nesrin Karamustafalioglu; Nesrin Tomruk; Aziz Yasan; Timucin Oral
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

7.  BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments.

Authors:  Sungho Maeng; Joshua G Hunsberger; Brandon Pearson; Peixiong Yuan; Yun Wang; Yanling Wei; Joseph McCammon; Robert J Schloesser; Rulun Zhou; Jing Du; Guang Chen; Bruce McEwen; John C Reed; Husseini K Manji
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

8.  A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.

Authors:  Roy H Perlis; Jordan W Smoller; Manuel A R Ferreira; Andrew McQuillin; Nick Bass; Jacob Lawrence; Gary S Sachs; Vishwajit Nimgaonkar; Edward M Scolnick; Hugh Gurling; Pamela Sklar; Shaun Purcell
Journal:  Am J Psychiatry       Date:  2009-05-15       Impact factor: 18.112

9.  Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study.

Authors:  Boris Birmaher; David Axelson; Benjamin Goldstein; Michael Strober; Mary Kay Gill; Jeffrey Hunt; Patricia Houck; Wonho Ha; Satish Iyengar; Eunice Kim; Shirley Yen; Heather Hower; Christianne Esposito-Smythers; Tina Goldstein; Neal Ryan; Martin Keller
Journal:  Am J Psychiatry       Date:  2009-05-15       Impact factor: 18.112

Review 10.  Neurocognitive and neuroimaging predictors of clinical outcome in bipolar disorder.

Authors:  Carrie E Bearden; Michelle Woogen; David C Glahn
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.